Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Dias, Flávia Regina Cruz, Liana Wermelinger de Matos, Maria de Fátima dos Santos Sampaio, Robert J. Carey, and Marinete Pinheiro Carrera. "Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist." Behavioural Brain Research 229, no. 1 (2012): 153-159.

Bustan, Yael, Adi Drapisz, David H. Ben Dor, Matan Avrahami, Maya Schwartz-Lifshitz, Abraham Weizman, and Ran Barzilay. "Elevated neutrophil to lymphocyte ratio in non-affective psychotic adolescent inpatients: Evidence for early association between inflammation and psychosis." Psychiatry research 262 (2018): 149-153.

Tan, M. L., Bailey A. Dyck, Joseph Gabriele, R. P. Daya, Nancy Thomas, Christal Sookram, Dipannita Basu, Mark A. Ferro, V. Z. Chong, and R. K. Mishra. "Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs." The pharmacogenomics journal 14, no. 1 (2014): 63-69.

Faugere, M., J-A. Micoulaud-Franchi, C. Faget-Agius, C. Lançon, M. Cermolacce, and R. Richieri. "High C-reactive protein levels are associated with depressive symptoms in schizophrenia." Journal of affective disorders 225 (2018): 671-675.

Pankowski, Daniel, Joachim Kowalski, and ?ukasz Gaw?da. "Skuteczno?? treningu metapoznawczego u osób choruj?cych na schizofreni?: narracyjny przegl?d systematyczny bada? opublikowanych w latach 2009–2015." Psychiatr. Pol 50, no. 4 (2016): 787-803.

Frydecka, Dorota, B?a?ej Misiak, Edyta Pawlak-Adamska, Lidia Karabon, Anna Tomkiewicz, Pawe? Sedlaczek, Andrzej Kiejna, and Jan Aleksander Besz?ej. "Sex differences in TGFB-? signaling with respect to age of onset and cognitive functioning in schizophrenia." Neuropsychiatric disease and treatment 11 (2015): 575.

Melka, Melkaye G., Christina A. Castellani, Benjamin I. Laufer, N. Rajakumar, Richard O’Reilly, and Shiva M. Singh. "Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis." Journal of molecular psychiatry 1, no. 1 (2013): 1-7.

Kumar, Devvarta. "Promoting insight into delusions: Issues and challenges in therapy." International journal of psychiatry in clinical practice 24, no. 2 (2020): 208-213.

Chengappa, KN Roy, Jaspreet S. Brar, Jessica M. Gannon, and Patricia J. Schlicht. "Adjunctive use of a standardized extract of Withania somnifera (Ashwagandha) to treat symptom exacerbation in schizophrenia: a randomized, double-blind, placebo-controlled study." The Journal of clinical psychiatry 79, no. 5 (2018): 0-0.

Yildiz, Mustafa, Zeynep Özaslan, Aysel Incedere, Ay?e Kircali, Fatma Kiras, and Kübra ?pçi. "The effect of psychosocial skills training and metacognitive training on social and cognitive functioning in schizophrenia." Archives of Neuropsychiatry 56, no. 2 (2019): 139.

Calcagno, B., D. Eyles, B. Van Alphen, and B. Van Swinderen. "Transient activation of dopaminergic neurons during development modulates visual responsiveness, locomotion and brain activity in a dopamine ontogeny model of schizophrenia." Translational psychiatry 3, no. 1 (2013): e206-e206.

Micoulaud-Franchi, Jean-Arthur, Mélanie Faugere, Laurent Boyer, Guillaume Fond, Raphaëlle Richieri, Catherine Faget, Michel Cermolacce, Pierre Philip, Jean Vion-Dury, and Christophe Lancon. "Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia." Schizophrenia research 165, no. 1 (2015): 94-96.

Cohen, O. S., T. W. Weickert, J. L. Hess, L. M. Paish, S. Y. McCoy, D. A. Rothmond, Cherrie Galletly et al. "A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples." Molecular psychiatry 21, no. 7 (2016): 975-982.

Orsolini, Laura, Fabiola Sarchione, Federica Vellante, Michele Fornaro, Ilaria Matarazzo, Giovanni Martinotti, Alessandro Valchera et al. "Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review." Current neuropharmacology 16, no. 5 (2018): 583-606.

Fernández-Sotos, P., A. Fernández-Caballero, and R. Rodriguez-Jimenez. "Virtual reality for psychosocial remediation in schizophrenia: a systematic review." The European Journal of Psychiatry 34, no. 1 (2020): 1-10.

Morita, Ken, Shuning He, Rados?aw P. Nowak, Jinhua Wang, Mark W. Zimmerman, Cong Fu, Adam D. Durbin et al. "Allosteric activators of protein phosphatase 2A display broad antitumor activity mediated by dephosphorylation of MYBL2." Cell 181, no. 3 (2020): 702-715.

Pan, Bo, Jiezhong Chen, Jiamei Lian, Xu-Feng Huang, and Chao Deng. "Unique effects of acute aripiprazole treatment on the dopamine D2 receptor downstream cAMP-PKA and Akt-GSK3? signalling pathways in rats." PloS one 10, no. 7 (2015): e0132722.

Bordia, Tanuja, J. Michael McIntosh, and Maryka Quik. "Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats." Journal of Pharmacology and Experimental Therapeutics 340, no. 3 (2012): 612-619.

Slokar, Gorjan, and Gregor Hasler. "Human endogenous retroviruses as pathogenic factors in the development of schizophrenia." Frontiers in psychiatry 6 (2016): 183.

Faugere, Melanie, J. A. Micoulaud-Franchi, Marine Alessandrini, Raphaëlle Richieri, Catherine Faget-Agius, Pascal Auquier, Christophe Lançon, and Laurent Boyer. "Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study." Scientific reports 5, no. 1 (2015): 1-7.